Methods of treating skin cancer by administering a PD-1 inhibitor
MYPI2025002758A0Undetermined Publication Date: 2017-11-13REGENERON PHARMACEUTICALS INC
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- MYPI2025002758
- Authority / Receiving Office
- MY · MY
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2017-05-12
- Filing Date
- 2017-05-12
- Publication Date
- 2017-11-13
Abstract
The present invention provides methods for treating, reducing the severity, or inhibiting the growth of cancer (e.g., skin cancer). The methods of the present invention comprise administering to a subject in need thereof a therapeutically effective amount of a programmed death 1 (PD-1) antagonist (e.g., an anti-PD-1 antibody). In certain embodiments, the skin cancer is cutaneous squamous cell carcinoma or basal cell carcinoma.
Need to check novelty before this filing date? Find Prior Art
